Global RNA Analysis And Transcriptomics Market Research Report 2024

Publication ID:

PB502240746

Publication Date:

February 23, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Transcriptomics and RNA analysis refers to the study of the transcriptome or the complete set of RNA transcripts which are produced by the genome under specific circumstances or in a specific cell.
The global RNA Analysis And Transcriptomics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for RNA Analysis And Transcriptomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for RNA Analysis And Transcriptomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for RNA Analysis And Transcriptomics in Academic Research Institutes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of RNA Analysis And Transcriptomics include Affymetrix Inc.(Thermo Fisher Scientific), Agilent Technologies, Inc., Bio-Rad Laboratories, GE Healthcare Systems(GE), Illumina, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich(Merck KGaA) and Fluidigm Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for RNA Analysis And Transcriptomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Analysis And Transcriptomics.
Report Scope
The RNA Analysis And Transcriptomics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNA Analysis And Transcriptomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Analysis And Transcriptomics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Affymetrix Inc.(Thermo Fisher Scientific)
Agilent Technologies, Inc.
Bio-Rad Laboratories
GE Healthcare Systems(GE)
Illumina, Inc.
Qiagen N.V.
F. Hoffmann-La Roche Ltd.
Sigma-Aldrich(Merck KGaA)
Fluidigm Corporation
Danaher Corporation
Acobiom
Lexogen GmbH
Promega Corporation
Segment by Type
Microarrays
Polymerase Chain Reaction
Sequencing Technologies
RNAI Gene Silencing
Segment by Application
Academic Research Institutes
Pharmaceutical Companies
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Analysis And Transcriptomics companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Analysis And Transcriptomics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Microarrays
1.2.3 Polymerase Chain Reaction
1.2.4 Sequencing Technologies
1.2.5 RNAI Gene Silencing
1.3 Market by Application
1.3.1 Global RNA Analysis And Transcriptomics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Academic Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Hospitals and Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Analysis And Transcriptomics Market Perspective (2019-2030)
2.2 RNA Analysis And Transcriptomics Growth Trends by Region
2.2.1 Global RNA Analysis And Transcriptomics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 RNA Analysis And Transcriptomics Historic Market Size by Region (2019-2024)
2.2.3 RNA Analysis And Transcriptomics Forecasted Market Size by Region (2025-2030)
2.3 RNA Analysis And Transcriptomics Market Dynamics
2.3.1 RNA Analysis And Transcriptomics Industry Trends
2.3.2 RNA Analysis And Transcriptomics Market Drivers
2.3.3 RNA Analysis And Transcriptomics Market Challenges
2.3.4 RNA Analysis And Transcriptomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Analysis And Transcriptomics Players by Revenue
3.1.1 Global Top RNA Analysis And Transcriptomics Players by Revenue (2019-2024)
3.1.2 Global RNA Analysis And Transcriptomics Revenue Market Share by Players (2019-2024)
3.2 Global RNA Analysis And Transcriptomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA Analysis And Transcriptomics Revenue
3.4 Global RNA Analysis And Transcriptomics Market Concentration Ratio
3.4.1 Global RNA Analysis And Transcriptomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Analysis And Transcriptomics Revenue in 2023
3.5 RNA Analysis And Transcriptomics Key Players Head office and Area Served
3.6 Key Players RNA Analysis And Transcriptomics Product Solution and Service
3.7 Date of Enter into RNA Analysis And Transcriptomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Analysis And Transcriptomics Breakdown Data by Type
4.1 Global RNA Analysis And Transcriptomics Historic Market Size by Type (2019-2024)
4.2 Global RNA Analysis And Transcriptomics Forecasted Market Size by Type (2025-2030)
5 RNA Analysis And Transcriptomics Breakdown Data by Application
5.1 Global RNA Analysis And Transcriptomics Historic Market Size by Application (2019-2024)
5.2 Global RNA Analysis And Transcriptomics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America RNA Analysis And Transcriptomics Market Size (2019-2030)
6.2 North America RNA Analysis And Transcriptomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America RNA Analysis And Transcriptomics Market Size by Country (2019-2024)
6.4 North America RNA Analysis And Transcriptomics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Analysis And Transcriptomics Market Size (2019-2030)
7.2 Europe RNA Analysis And Transcriptomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe RNA Analysis And Transcriptomics Market Size by Country (2019-2024)
7.4 Europe RNA Analysis And Transcriptomics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Analysis And Transcriptomics Market Size (2019-2030)
8.2 Asia-Pacific RNA Analysis And Transcriptomics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific RNA Analysis And Transcriptomics Market Size by Region (2019-2024)
8.4 Asia-Pacific RNA Analysis And Transcriptomics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Analysis And Transcriptomics Market Size (2019-2030)
9.2 Latin America RNA Analysis And Transcriptomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America RNA Analysis And Transcriptomics Market Size by Country (2019-2024)
9.4 Latin America RNA Analysis And Transcriptomics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Analysis And Transcriptomics Market Size (2019-2030)
10.2 Middle East & Africa RNA Analysis And Transcriptomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa RNA Analysis And Transcriptomics Market Size by Country (2019-2024)
10.4 Middle East & Africa RNA Analysis And Transcriptomics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Affymetrix Inc.(Thermo Fisher Scientific)
11.1.1 Affymetrix Inc.(Thermo Fisher Scientific) Company Detail
11.1.2 Affymetrix Inc.(Thermo Fisher Scientific) Business Overview
11.1.3 Affymetrix Inc.(Thermo Fisher Scientific) RNA Analysis And Transcriptomics Introduction
11.1.4 Affymetrix Inc.(Thermo Fisher Scientific) Revenue in RNA Analysis And Transcriptomics Business (2019-2024)
11.1.5 Affymetrix Inc.(Thermo Fisher Scientific) Recent Development
11.2 Agilent Technologies, Inc.
11.2.1 Agilent Technologies, Inc. Company Detail
11.2.2 Agilent Technologies, Inc. Business Overview
11.2.3 Agilent Technologies, Inc. RNA Analysis And Transcriptomics Introduction
11.2.4 Agilent Technologies, Inc. Revenue in RNA Analysis And Transcriptomics Business (2019-2024)
11.2.5 Agilent Technologies, Inc. Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories RNA Analysis And Transcriptomics Introduction
11.3.4 Bio-Rad Laboratories Revenue in RNA Analysis And Transcriptomics Business (2019-2024)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 GE Healthcare Systems(GE)
11.4.1 GE Healthcare Systems(GE) Company Detail
11.4.2 GE Healthcare Systems(GE) Business Overview
11.4.3 GE Healthcare Systems(GE) RNA Analysis And Transcriptomics Introduction
11.4.4 GE Healthcare Systems(GE) Revenue in RNA Analysis And Transcriptomics Business (2019-2024)
11.4.5 GE Healthcare Systems(GE) Recent Development
11.5 Illumina, Inc.
11.5.1 Illumina, Inc. Company Detail
11.5.2 Illumina, Inc. Business Overview
11.5.3 Illumina, Inc. RNA Analysis And Transcriptomics Introduction
11.5.4 Illumina, Inc. Revenue in RNA Analysis And Transcriptomics Business (2019-2024)
11.5.5 Illumina, Inc. Recent Development
11.6 Qiagen N.V.
11.6.1 Qiagen N.V. Company Detail
11.6.2 Qiagen N.V. Business Overview
11.6.3 Qiagen N.V. RNA Analysis And Transcriptomics Introduction
11.6.4 Qiagen N.V. Revenue in RNA Analysis And Transcriptomics Business (2019-2024)
11.6.5 Qiagen N.V. Recent Development
11.7 F. Hoffmann-La Roche Ltd.
11.7.1 F. Hoffmann-La Roche Ltd. Company Detail
11.7.2 F. Hoffmann-La Roche Ltd. Business Overview
11.7.3 F. Hoffmann-La Roche Ltd. RNA Analysis And Transcriptomics Introduction
11.7.4 F. Hoffmann-La Roche Ltd. Revenue in RNA Analysis And Transcriptomics Business (2019-2024)
11.7.5 F. Hoffmann-La Roche Ltd. Recent Development
11.8 Sigma-Aldrich(Merck KGaA)
11.8.1 Sigma-Aldrich(Merck KGaA) Company Detail
11.8.2 Sigma-Aldrich(Merck KGaA) Business Overview
11.8.3 Sigma-Aldrich(Merck KGaA) RNA Analysis And Transcriptomics Introduction
11.8.4 Sigma-Aldrich(Merck KGaA) Revenue in RNA Analysis And Transcriptomics Business (2019-2024)
11.8.5 Sigma-Aldrich(Merck KGaA) Recent Development
11.9 Fluidigm Corporation
11.9.1 Fluidigm Corporation Company Detail
11.9.2 Fluidigm Corporation Business Overview
11.9.3 Fluidigm Corporation RNA Analysis And Transcriptomics Introduction
11.9.4 Fluidigm Corporation Revenue in RNA Analysis And Transcriptomics Business (2019-2024)
11.9.5 Fluidigm Corporation Recent Development
11.10 Danaher Corporation
11.10.1 Danaher Corporation Company Detail
11.10.2 Danaher Corporation Business Overview
11.10.3 Danaher Corporation RNA Analysis And Transcriptomics Introduction
11.10.4 Danaher Corporation Revenue in RNA Analysis And Transcriptomics Business (2019-2024)
11.10.5 Danaher Corporation Recent Development
11.11 Acobiom
11.11.1 Acobiom Company Detail
11.11.2 Acobiom Business Overview
11.11.3 Acobiom RNA Analysis And Transcriptomics Introduction
11.11.4 Acobiom Revenue in RNA Analysis And Transcriptomics Business (2019-2024)
11.11.5 Acobiom Recent Development
11.12 Lexogen GmbH
11.12.1 Lexogen GmbH Company Detail
11.12.2 Lexogen GmbH Business Overview
11.12.3 Lexogen GmbH RNA Analysis And Transcriptomics Introduction
11.12.4 Lexogen GmbH Revenue in RNA Analysis And Transcriptomics Business (2019-2024)
11.12.5 Lexogen GmbH Recent Development
11.13 Promega Corporation
11.13.1 Promega Corporation Company Detail
11.13.2 Promega Corporation Business Overview
11.13.3 Promega Corporation RNA Analysis And Transcriptomics Introduction
11.13.4 Promega Corporation Revenue in RNA Analysis And Transcriptomics Business (2019-2024)
11.13.5 Promega Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Affymetrix Inc.(Thermo Fisher Scientific)
Agilent Technologies, Inc.
Bio-Rad Laboratories
GE Healthcare Systems(GE)
Illumina, Inc.
Qiagen N.V.
F. Hoffmann-La Roche Ltd.
Sigma-Aldrich(Merck KGaA)
Fluidigm Corporation
Danaher Corporation
Acobiom
Lexogen GmbH
Promega Corporation

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂